RYK and glioblastoma: Our results demonstrated that increased expression of FRMD6 reduces activity of c-Met, PDGFRα and/or β, and RYK RTKs in U87MG and U251 GBM cells (Figure 6A–6B, small, large and intermediate circles, respectively).